Views & Analysis | Perspectives on pharma industry issues

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Menopause is an urgent global health issue: Bayer’s Cecilia ...

R&D

Wooden pawns on top of wooden block named BOARD

Changing Faces: Board of Director and Advisory Board hires, ...

September’s boardroom moves brought seasoned pharma executives, investors, and scientific leaders into new governance and advisory roles across the life sciences sector.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

R&D

Digital box and pills, supply chain concept for pharma

From reactive to predictive: How data is redefining pharma l...

Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight.

R&D

Depressed woman looks out rain spattered window in city

Removing barriers in treatment-resistant depression

pharmaphorum speaks with Hans Eriksson, psychiatrist and CMO of FundaMental Pharma, about why treatment resistance remains such a challenge.

Views & Analysis

Improving oncology KOL engagement

Combining technology with human insights is a powerful tool in identifying and engaging effectively with oncology experts.

Views & Analysis

Social media concept. Technological abstract background.

Making video do more for pharma brand marketing

Innovations such as interactivity are making video more like the web in terms of delivering heightened results from marketing, including deeper engagement, ISI compliance and audience insights.

Views & Analysis

Local partnerships key to pharma’s success in China

China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.

Sales & Marketing

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Sales & Marketing

Hiring of investor at meeting, men and women

Changing Faces: Agency, consultancy, and investor hires, Aug...

August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.

Digital

Better analytics leads to fewer regulator questions

Stronger data analytics is cutting the number of questions regulators ask about intensified processes.

Digital

pharmaphorum podcast Episode 280, Robbie Tyrie, Torridon Cyber

AI governance & cybersecurity: Torridon Cyber’s Robbie Tyrie

Robbie Tyrie, founder and managing director of Torridon Cyber, talks cybersecurity when it comes to AI, pharma companies, and health systems.

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Oncology

Dr Michael Bauer on Quantro’s mission to drug the “undruggab...

Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.

Oncology

In vivo CAR-T can solve the delivery problem – but solid tum...

A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.

Oncology

Unlocking the scalability of allogeneic CAR-T

Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.

Patients

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Patients

From bedside to breakthroughs: Reimagining the human experie...

Patients should be involved in the programme design process from the beginning, as co-creators with full influence over the outcome.

Patients

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks